You are here

  • Home
  • Archive
  • Volume 12, Issue 3
  • Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity

Article metrics

Article menu
Basic tumor immunology
Original research
Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity

 

Online download statistics by month:

Online download statistics by month: March 2024 to July 2025

AbstractFullPdf
Mar 2024464472257
Apr 2024365366184
May 202426326376
Jun 202414514674
Jul 202435435588
Aug 202411711656
Sep 202410510566
Oct 202411211352
Nov 202415816055
Dec 202414414756
Jan 202513313454
Feb 202525325365
Mar 202513413468
Apr 2025202202102
May 202514414471
Jun 2025848428
Jul 2025110
Total317831951352